Why the study?
Does a large magnitude decrease in arterial carbon dioxide (≥25 mmHg) at ECMO initiation increase mortality in pediatric patients?
Does a large magnitude decrease in arterial carbon dioxide (≥25 mmHg) at ECMO initiation increase mortality in pediatric patients?
A rapid, large-magnitude decrease in arterial carbon dioxide (≥25 mmHg) upon ECMO initiation is independently associated with increased mortality in pediatric patients, identifying a potentially modifiable target for ECMO management.
No takes yet. Share an insight, caveat, or question.
Large paCO2 drops at pediatric ECMO initiation were associated with mortality; leaves open whether gradual correction improves outcomes.
Bembea et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: